Pennsylvania Senators Approve Bipartisan Cannabis Bill To Create New Regulatory Body

Pennsylvania senators have approved a bipartisan bill that would create a
new regulatory body to oversee the state’s existing medical cannabis program
and intoxicating hemp products, while preparing to eventually handle the
adult-use cannabis market as well.

The Senate Law & Justice Committee advanced the legislation from Sen. Dan
Laughlin (R), who chairs the panel, in a 10-1 vote on Tuesday.

Laughlin said ahead of the vote that the proposed Cannabis Control Board
(CCB) will “ensure accountability, consistency and public safety.”

He criticized the Department of Health, which currently oversees medical
cannabis, for a program that is “bogged down by slow product, slow
responses, inconsistent oversight and a lack of clarity that has frustrated
both patients and legitimate businesses.”

The GOP senator also expressed concerns over unregulated hemp products that
are “being sold openly in gas stations, vape shops and convenience stores
across this commonwealth,” saying they are “often marketed with no testing,
no labeling and no age restrictions.”

While Laughlin said the bill is “not about legalizing adult-use cannabis,”
which he has separately supported, it would establish a regulatory
infrastructure that could be used to oversee such a program if eventually
enacted into law.

The senator previewed the measure in May, writing that Pennsylvania should
take initial steps to make sure the state is “ready to act when
legalization becomes law” by establishing a CCB now.

“Legalization of adult-use cannabis in Pennsylvania is no longer a matter
of if, it is when. And when that day comes, the state should not be
scrambling to build a regulatory system from scratch,” he said. “A
transparent, efficient framework should already be in place, one designed
to support a safe, well-regulated cannabis industry from day one.”

For now, however, the focus of the board would be on medical cannabis and
hemp products.

In a press release sent when the legislation was filed, Laughlin said that
“since the 2016 legalization of medical marijuana in Pennsylvania, the
state Department of Health’s oversight of the Medical Marijuana Program has
been glaringly inconsistent, inefficient and lacking transparency.”

“That coupled with the concerning unregulated intoxicating hemp products
being proliferated across our commonwealth warrants the need for a
dedicated regulatory board to eliminate these inconsistencies, enhance
transparency and provide the structure needed to responsibly manage this
industry,” he said. “One of the first tasks this board will tackle is
regulating these intoxicating hemp products. Without proper oversight of
these products, they will continue to thrive in this legal gray area and be
sold without proper age guidelines, labeling and without the collection of
any tax revenue.”

In a cosponsorship memo circulated earlier this year, Laughlin said his
bill would “transfer regulatory control of the Medical Marijuana Program to
the CCB, ensuring continuity, efficiency, and improved oversight of medical
cannabis businesses and patient access.” It would further “establish
uniform safety standards to protect consumers from untested and potentially
harmful products.”

The bill text itself also doesn’t contain an explicit references to
adult-use, or recreational, marijuana, and it would not enact legalization
on its own. But the description indicates that the sponsors feel the
current regulatory regime under the Pennsylvania Department of Health
should be replaced with a more targeted agency that would ostensibly be
suited to oversee an adult-use market if lawmakers move to end prohibition.

“By consolidating oversight under a single regulatory board, we can
eliminate inconsistencies, enhance transparency, and provide the structure
needed to responsibly manage this industry,” the memo says.

Most of the bill that advanced out of committee describes the process of
establishing the CCB, with details about the selection criteria and other
procedural information. The duties section of the legislation lists various
authorizations for the board, including members’ ability to conduct
investigations, promulgate regulations, consult with other departments and
more to achieve its oversight goals.

Meanwhile in Pennsylvania, bipartisan senators earlier this month
introduced a bill that would allow terminally ill patients to use of
medical marijuana in hospitals.

This comes as state lawmakers continue to push for adult-use marijuana
legalization in the commonwealth.


*— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug
policy bills in state legislatures and Congress this year. Patreon
supporters pledging at least $25/month get access to our interactive maps,
charts and hearing calendar so they don’t miss any developments.*


*Learn more about our marijuana bill tracker and become a supporter on
Patreon to get access. —*

A top aide to Pennsylvania’s governor said last month, however, that lawmakers
should stop introducing new competing legalization bills and instead focus
on building consensus on the issue—while emphasizing that any measure that
advances needs to contain equity provisions if the governor is going to
sign it into law.

Laughlin, for his part, said in August that the House “needs to pass the
language in my bill and send it to my committee” after which point he “can
negotiate with the Senate and the governor.”

The Democratic-controlled House, however, has already advanced a
legalization proposal this session that called for a state-run sales model.
That measure was quickly quashed in Laughlin’s Senate committee, however,
with the GOP lawmaker and others insisting that a more traditional approach
of licensing privates businesses would have a better shot.

Laughlin separately said recently that supporters are “picking up votes” to
enact the reform this session.

Gov. Josh Shapiro (D), for his part, said last month that he won’t
“concede” on his plan to legalize adult-use cannabis through the budget.

Meanwhile, the leading Republican candidate in the race to become the next
governor of Pennsylvania dodged a question about her stance on legalizing
marijuana—saying she doesn’t have a “policy position” on the issue and
arguing that the sitting governor’s proposal for reform “way, way
overstated” potential revenue.

The candidate, Pennsylvania Treasurer Stacy Garrity (R), pointed to
neighboring Ohio, which launched its own adult-use cannabis market this
year, saying “they generated about $115 million in revenue.” And while the
populations of both states are relatively comparable, Shapiro’s budget projected
$536.5 million in cannabis revenue in the first fiscal year of
implementation.

She did, however, say that if Pennsylvania moves forward on enacting the
reform, she’ll “make sure that it’s banked appropriately.”

Meanwhile, a Pennsylvania Democratic senator recently said that federal
marijuana rescheduling would be “very influential” in advancing
legalization in his state, giving “political cover” to GOP members on the
fence about reform.

Sen. Sharif Street (D) discussed the status of cannabis legalization
efforts in the Keystone State, including a bipartisan proposal to end
prohibition that he filed alongside Laughlin in July.

The legalization bill with a state-run sales model that passed the House
isn’t necessarily dead for the session as a vehicle to advance reform,
however. And Democrats in the chamber recently called on voters to pressure
state senators to sign off on the cannabis measure, arguing that it would
benefit health and safety and bring in billions of dollars in revenue for
the commonwealth.

Polls have shown bipartisan support for legalization among voters, but the
reform has consistently stalled in the legislature, due largely to GOP
opposition. But not all Republican members are against the policy
change—and one recently said she felt her party should seize the
“opportunity to snatch” the issue from Democrats.

In addition to pushback from Senate Majority Leader Pittman, another
Republican, Sen. Scott Martin, who chairs the influential Appropriations
Committee, said earlier this month that he didn’t plan to move on any
adult-use legalization bills.

Separately, just days after Laughlin and Street filed their measure, Reps.
Emily Kinkead (D) and Abby Major (R)—alongside eight other cosponsors—filed
legislation in the House to enact the reform. The pair have previously championed
other proposals to end prohibition.

Separately, a recent poll found that Pennsylvania voters say they favor a
model where cannabis is sold by licensed private businesses rather than
through a system of state-run stores.

Meanwhile, a Democratic lawmaker recently filed a bill that seeks to require
employers to cover the costs of medical cannabis for qualifying patients
receiving workers’ compensation.

The post Pennsylvania Senators Approve Bipartisan Cannabis Bill To Create
New Regulatory Body appeared first on Marijuana Moment.